Sordarin oxazepine derivatives as potent antifungal agents.

Michael H Serrano-Wu, Denis R St Laurent, Yijun Chen, Stella Huang, Kin-Ray Lam, James A Matson, Charles E Mazzucco, Terry M Stickle, Thomas P Tully, Henry S Wong, Dolatrai M Vyas, Balu N Balasubramanian
Author Information
  1. Michael H Serrano-Wu: Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA. michael.serrano-wu@bms.com

Abstract

The synthesis and biological activity of sordarin oxazepine derivatives are described. The key step features a regioselective oxidation of an unprotected triol followed by double reductive amination to afford the ring-closed products. The spectrum of antifungal activity for these novel derivatives includes coverage of Candida albicans, Candida glabrata, and Cryptococcus neoformans.

MeSH Term

Antifungal Agents
Candida albicans
Candida glabrata
Cryptococcus neoformans
Fungi
Hydrogen Bonding
Indenes
Microbial Sensitivity Tests
Oxazepines
Structure-Activity Relationship

Chemicals

Antifungal Agents
Indenes
Oxazepines
sordarin

Word Cloud

Created with Highcharts 10.0.0derivativesactivityoxazepineantifungalCandidasynthesisbiologicalsordarindescribedkeystepfeaturesregioselectiveoxidationunprotectedtriolfolloweddoublereductiveaminationaffordring-closedproductsspectrumnovelincludescoveragealbicansglabrataCryptococcusneoformansSordarinpotentagents

Similar Articles

Cited By (7)